Bringing FAIRness to FDA data through visualization.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37223271.
- Also identified by DOI 10.1016/j.patter.2023.100755 and PMC identifier 10201289.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Improving representation and inclusion in clinical trials for new medicinal products has been a high priority for federal agencies for over 2 decades, but data to evaluate progress have been difficult to access. In this issue of <i>Patterns</i>, Carmeli et al. provide a novel approach to aggregating and visualizing existing data to improve transparency and research.